Interferon-γ is not a universal requirement for islet allograft survival

Transplantation

Volumn 74, Issue 4, 2002, Pages 472-477

  Nicolls, Mark R ^a,b   Coulombe, Marilyne ^b   Diamond, Andrew S ^b   Beilke, Joshua ^b   Gill, Ronald G ^b  

^a Division of Pulmonary Sciences and Critical Care Medicine   (United States)

^b UNIVERSITY OF COLORADO DENVER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 LIGAND MONOCLONAL ANTIBODY; GAMMA INTERFERON; IMMUNOGLOBULIN G; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MONOCLONAL ANTIBODY; OKT 4;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOLOGICAL TOLERANCE; IMMUNOREACTIVITY; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PANCREAS ISLET; PRIORITY JOURNAL; TH2 CELL;

EID: 0037183574     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200208270-00007     Document Type: Article

References (54)

1. CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2
2. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways
3. Prevention of Th1 responses is critical for tolerance
4. Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection
5. Murine interleukin 4 transgenic heart allograft survival prolonged with down-regulation of the Th1 cytokine mRNA in grafts
6. Targeting signal 1 through CD45RB synergizes with CD40 ligand blockade and promotes long term engraftment and tolerance in stringent transplant models
7. Heart allografts in murine systems: The differential activation of TH2-like effector cells in peripheral tolerance
8. Type 2 helper T cell-type cytokines and the development of "infectious" tolerance in rat cardiac allograft recipients
9. Regulatory functions of self-restricted MHC class II allopeptide-specific Th2 clones in vivo
10. IL-2 knockout recipient mice reject islet cell allografts
11. Prolonged islet allograft acceptance in the absence of interleukin 4 expression
12. Are Th2 helper T lymphocytes beneficial, deleterious, or irrelevant in promoting allograft survival?
13. Blocking the CD28-B7 T cell costimulation pathway induces long term cardiac allograft acceptance in the absence of IL-4
14. Alloantigen-reactive Th1 development in IL-12-deficient mice
15. + suppressor T cells that are not dependent upon IL-4
16. Impaired alloantigen-mediated T cell apoptosis and failure to induce long-term allograft survival in IL-2-deficient mice
17. Interleukin-10 (IL-10) augments allograft arterial disease
18. Critical roles for IL-4, IL-5 and eosinophils in chronic skin allograft rejection
19. Increased expression of interleukin-4 during allograft rejection
20. Evidence for immune regulation in the induction of transplantation tolerance: A conditional but limited role for IL-4
21. Anti-LFA-1 therapy induces long term islet allograft acceptance in the absence of IFN-γ or IL-4
22. + T cells responsive through the indirect pathway can mediate skin graft rejection in the absence ofinterferon-γ
23. Role of STAT4 and STAT6 signaling in allograft rejection and CTLA4-Ig-mediated tolerance
24. The role of CD154-CD40 versus CD28-B7 costimulatory pathways in regulating allogenic Th1 and Th2 responses in vivo
25. Interleukin-2 and interferon-gamma double knockout mice reject heterotopic cardiac allografts
26. Critical role for IL-4 in the development of transplant arteriosclerosis in the absence of CD40-CD154 costimulation
27. + cells and CD40-CD40 ligand interactions
28. Distinct mechanisms for the induction and maintenance of allograft tolerance with CTLA4-Fc treatment
29. + T cells, interferon-γ and CTLA4
30. IFN-γ is critical for long-term allograft survival induced by blocking the CD28 and CD40 ligand T cell costimulation pathways
31. Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal anti-body GK 1.5: Similarity of L3T4 to the human Leu 3/T4 molecule
32. Tolerance induction to cultured islet allografts. I. Characterization of the tolerant state
33. + T-cell responses
34. Islet allograft survival after a single course of treatment of recipient with antibody to L3T4
35. + T cell in allograft rejection
36. Anti-CD4 monoclonal antibody-induced allograft tolerance in rats despite persistence of donor-reactive T cells
37. The functional significance, distribution, and structure of LFA-1, LFA-2, and LFA-3: Cell surface antigens associated with CTL-target interactions
38. Acute rejection of vascularized heart allografts in the absence of IFNγ
39. + T cell-mediated rejection of pancreatic islet allografts
40. Regulation of alloantigen-mediated T-cell proliferation by endogenous interferon-γ: Implications for long-term acceptance
41. Differential susceptibility of heart, skin and islet allografts to T cell-mediated rejection
42. Tolerance to antigen-presenting cell-depleted islet allografts is CD4 T cell dependent
43. The LFA-1 ligand ICAM-1 provides an important costimulatory signal for T cell receptor-mediated activation of resting T cells
44. Signaling pathways activated by leukocyte function-associated Ag-l-dependent costimulation
45. + T cell proliferation requires phosphatidylinositol 3-kinase activity
46. + T cells are poorly costimulated by ICAM-1
47. + T cells
48. + T cell activation and cytolytic function in the absence of LFA-1 cannot be restored by increased TCR signaling
49. Distinct roles for LFA-1 and CD28 during activation of naive T cells: Adhesion versus costimulation
50. +)T cells play a critical role in costimulation blockade-resistant allograft rejection
51. Antigen-presenting cells for unprimed T cells
52. Genetic characterization of strain differences in the ability to mediate CD40/CD28-independent rejection of skin allografts
53. + T cells and prolonged graft survival in a CTLA4-dependent manner
54. Human lymphocyte function associated antigen (LFA-1): Identification of multiple antigenic epitopes and their relationship to CTL-mediated cytotoxicity